Xtant Medical Holdings, Inc. stock is up 12.82% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 13 December’s closed higher than November. 100% of analysts rate it a buy.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and osteoinductive potential of human bone.